AlfaCell

Site-Specific Integration Platform for Cell Line Development

Learn More

AlfaMedX

AI-enabled Cell Culture Media Development Platform

Learn More

AlfaOPA

AI-enabled No-screening Cell Culture Media Optimization Platform

Learn More

Please select your specific application and get an impression on the enormous capabilities of our various platforms

Applications

Biopharmaceutical
IVD
Synthetic Biology
Others

News and Events

2025-04-14

Great Bay Bio and Chime Biologics Deepen Strategic Collaboration Using AI to Accelerate the Development of Biopharmaceutical
2025-01-21

Great Bay Bio Partners with Prof Chen from MIT to Co-develop Novel Tumor Antibody
2024-12-30

Great Bay Bio Recognized as One of the Top 50 Innovative Biotechnology Companies in Guangdong-Hong Kong-Macao Greater Bay Area Award 2024
2024-12-16

Great Bay Bio Completes First Close of Series B Financing

Great Bay Bio and Chime Biologics Deepen Strategic Collaboration Using AI to Accelerate the Development of Biopharmaceutical

Learn More

Great Bay Bio Partners with Prof Chen from MIT to Co-develop Novel Tumor Antibody

Recently, Great Bay Bio (GBB) partnered with Professor JZ Chen from the Koch Institute for Integrative Cancer Research

Great Bay Bio Recognized as One of the Top 50 Innovative Biotechnology Companies in Guangdong-Hong Kong-Macao Greater Bay Area Award 2024

The Guangdong-Hong Kong-Macao Greater Bay Area Biotech Innovation Summit and the 7th Top 50 Innovative Biotech Compani

Great Bay Bio Completes First Close of Series B Financing

Hong Kong December 16, 2024 Great Bay Bio (GBB) is thrilled to announce the successful first close of its Series B
Message